Synlett 2008(16): 2487-2490  
DOI: 10.1055/s-2008-1078259
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Asymmetric 1,4-Addition of Arylboronic Acids to α,β-Unsaturated Esters Catalyzed by Dicationic Palladium(II)-Chiraphos Complex for Short-Step Synthesis of SmithKline Beecham’s Endothelin Receptor Antagonist

Takashi Nishikataa, Shunsuke Kiyomurab, Yasunori Yamamotob, Norio Miyaura*b
a Innovation Plaza Hokkaido, Japan Science and Technology Agency, Sapporo 060-0819, Japan
b Division of Chemical Process Engineering, Graduate School of Engineering, Hokkaido University, Sapporo 060-8628, Japan
Fax: +81(11)7066561; e-Mail: miyaura@eng.hokudai.ac.jp;
Weitere Informationen

Publikationsverlauf

Received 13 June 2008
Publikationsdatum:
21. August 2008 (online)

Abstract

An asymmetric 1,4-addition of arylboronic acids to RCH=CHCO2Ar (Ar = Ph or 4-acetylphenyl) was carried out at 50 ˚C in aqueous acetone in the presence of [Pd(chiraphos)(PhCN)2](SbF6)2. The reaction gave optically active β-aryl esters in up to 98% ee. The protocol provided a simple access to an endothelin receptor antagonist reported by SmithKline Beecham.

    References and Notes

  • 1a Kurihara K. Sugishita N. Oshita K. Piao D. Yamamoto Y. Miyaura N. J. Organomet. Chem.  2007,  692:  428 
  • 1b Hayashi T. Yamasaki K. Chem. Rev.  2003,  103:  2829 
  • 1c Takaya Y. Ogasawara M. Hayashi T. Sakai M. Miyaura N. J. Am. Chem. Soc.  1998,  120:  5579 
  • 2a He P. Lu Y. Dong C.-G. Hu Q.-S. Org. Lett.  2007,  9:  343 
  • 2b Lin S. Lu X. Tetrahedron Lett.  2006,  47:  7167 
  • 2c Denmark SE. Amishiro N. J. Org. Chem.  2003,  68:  6997 
  • 2d Nishikata T. Yamamoto Y. Miyaura N. Angew. Chem. Int. Ed.  2003,  42:  2768 
  • 2e Ohe K. Uemura S. Bull. Chem. Soc. Jpn.  2003,  76:  1423 
  • 2f For a mechanistic study, see: Nishikata T. Yamamoto Y. Miyaura N. Organometallics  2004,  23:  4317 
  • 3a Zhang T. Shi M. Chem. Eur. J.  2008,  14:  3759 
  • 3b Song J. Shen Q. Xu F. Lu X. Org. Lett.  2007,  9:  2947 
  • 3c Sieber JD. Liu S. Morken JP. J. Am. Chem. Soc.  2007,  129:  2214 
  • 3d Suzuma Y. Yamamoto T. Ohta T. Ito Y. Chem. Lett.  2007,  36:  470 
  • 3e Gini F. Hessen B. Minnaard AJ. Org. Lett.  2005,  7:  5309 
  • 4a Yamamoto Y. Nishikata T. Miyaura N. Pure Appl. Chem.  2008,  80:  807 
  • 4b Nishikata T. Yamamoto Y. Miyaura N. Adv. Synth. Catal.  2007,  349:  1759 
  • 4c Nishikata T. Yamamoto Y. Gridnev ID. Miyaura N. Organometallics  2005,  24:  5025 
  • 4d Nishikata T. Yamamoto Y. Miyaura N. Chem. Lett.  2005,  34:  720 
  • 4e Nishikata T. Yamamoto Y. Miyaura N. Chem. Commun.  2004,  1822 
  • For application of Pd-catalyzed 1,4-addition reaction, see:
  • 4f Kobayashi K. Nishikata T. Yamamoto Y. Miyaura N. Bull. Chem. Soc. Jpn.  2008,  in press
  • 4g Nishikata T. Yamamoto Y. Miyaura N. Tetrahedron Lett.  2007,  48:  4007 
  • 4h Nishikata T. Yamamoto Y. Miyaura N. Chem. Lett.  2007,  36:  1442 
  • 4i Nishikata T. Kobayashi Y. Kobayashi K. Yamamoto Y. Miyaura N. Synlett  2007,  3055 
  • 4j Itoh T. Mase T. Nishikata T. Iyama T. Tachikawa H. Kobayashi Y. Yamamoto Y. Miyaura N. Tetrahedron  2006,  62:  9610 
  • 5a Du X. Suguro M. Hirabayashi K. Mori A. Nishikata T. Hagiwara N. Kawata K. Okeda T. Wang H.-F. Fugami K. Kosugi M. Org. Lett.  2001,  3:  3313 
  • 5b Cho CS. Motofusa S. Uemura S. Tetrahedron Lett.  1994,  35:  1739 
  • 6 Mori A. Danda Y. Fujii T. Hirabayashi K. Osakada K. J. Am. Chem. Soc.  2001,  123:  10774 
  • 7 Koike T. Du X. Sanada T. Danda Y. Mori A. Angew. Chem. Int. Ed.  2003,  42:  89 
  • 8 Farrington EJ. Brown JM. Barnard CFJ. Rowsell E. Angew. Chem. Int. Ed.  2002,  41:  169 
  • 9 Beletskaya IP. Cheprakov AV. Chem. Rev.  2000,  100:  3009 
  • 10 Arai Y. Ueda K. Xie J. Masaki Y. Chem. Pharm. Bull.  2001,  49:  1609 
  • 11a Clark WM. Tickner-Eldridge AM. Huang GK. Pridgen LN. Olsen MA. Mills RJ. Lantos I. Baine NH. J. Am. Chem. Soc.  1998,  120:  4550 
  • 11b Elliott JD. Amparo M. Cousins RD. Gao A. Leber JD. Erhard KF. Nambi P. Elshourbagy NA. Kumar C. Lee JA. Bean JW. Brooks CP. Feuerstein G. Ruffolo RR., Jr. Weinstock J. Gleason JG. Peishoff CE. Ohlstein EH. J. Med. Chem.  1994,  37:  1553 
  • 12a Kato Y. Niiyama K. Nemoto T. Jona H. Akao A. Okada S. Song ZJ. Zhao M. Tsuchiya Y. Tomimoto K. Mase T. Tetrahedron  2002,  58:  3409 
  • 12b Song ZJ. Zhao M. Frey J. Li L. Tan CY. Chen DM. Tschaen R. Tillyer EJJ. Grabowski L. Volante R. Reider PJ. Kato Y. Okada S. Nemoto T. Sato H. Akao A. Mase T. Org. Lett.  2001,  3:  3357 
13

General Procedure: A flask charged with [Pd((S,S)-chiraphos)(PhCN)2](SbF6)2 [(S,S)-3; 1 mol%], ArB(OH)2 (1.5 mmol) and 1 (0.5 mmol) was flushed with nitrogen. Acetone (2 mL) and H2O (0.2 mL) were then added. After stirring for 20 h at 50 ˚C, the product was isolated by chromatography on silica gel. The enantiomer excess was determined by Chiral HPLC using Daicel Chiralpak IA, IB or IC.